查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1760650

下一代肿瘤设备和解决方案全球市场报告（2025年）

Next-Generation Oncology Devices And Solutions Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年，下一代肿瘤设备和解决方案市场规模将快速成长。到2029年，该市场规模将达到327.3亿美元，复合年增长率为18.6%。预测期内，预期成长将受到以下因素的推动：全球人口老化、肿瘤新兴企业投资增加、医疗成本上涨、对非侵入性或微创诊断的需求成长以及医疗基础设施的不断发展。预测期内的主要趋势包括人工智慧辅助诊断影像、液态切片的进步、个人化医疗平台、穿戴式健康监测设备、机器人技术和微创手术工具。

癌症发生率的上升预计将推动下一代肿瘤设备和解决方案市场的扩张。癌症是一种以异常细胞不受控制地生长为特征的疾病，异常细胞会扩散到身体的其他部位并破坏正常功能。癌症发生率的上升主要是由于人口老化，因为罹患癌症的风险随着年龄的增长而增加。下一代肿瘤设备和解决方案透过实现更早的发现、更准确的诊断和个人化治疗来帮助应对这一增长。例如，美国非营利组织美国癌症协会估计，到 2024 年 1 月，美国癌症死亡人数将超过 611,000 人，相当于每天超过 1,600 人死亡。因此，癌症发生率的上升是下一代肿瘤设备和解决方案市场成长的主要驱动力。

新一代肿瘤设备和解决方案市场的主要企业正专注于技术创新，例如次世代定序仪(NGS) 标靶富集解决方案，以改善对罕见基因突变的检测，提高定序准确性，并加速癌症诊断和治疗决策。 NGS 标靶富集解决方案是一种选择性捕获和富集特定 DNA 或 RNA 区域的技术，可更准确、更有效地分析与癌症和其他疾病相关的基因突变。例如，2025 年 4 月，美国生物技术公司 Integrated DNA Technologies (IDT) 推出了 xGen Hybridization and Wash v3 试剂盒，这是一款先进的杂合反应捕获解决方案，旨在透过简化 NGS 工作流程来加速癌症研究。该套件将杂合反应时间缩短至仅需一小时，使研究人员能够在一次运行中完成从样品製备到定序的所有过程。透过消除对加热缓衝液的需求并将手动操作时间减少 20%，该解决方案非常适合自动化，是高通量应用的理想选择。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场宏观经济情境：包括利率、通货膨胀、地缘政治、贸易战、关税以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球下一代肿瘤设备和解决方案市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素、限制因素）
  • 最终用途产业分析
  • 全球下一代肿瘤设备和解决方案市场：增长率分析
  • 全球下一代肿瘤设备和解决方案市场规模和成长率：实际成果值，2019-2024 年
  • 全球下一代肿瘤设备和解决方案市场规模和成长率：预测，2024-2029 年，2034 年
  • 全球下一代肿瘤设备和解决方案市场：总可用市场（TAM）

第六章市场区隔

  • 全球下一代肿瘤设备和解决方案市场（按癌症类型、实际成果值和预测），2019-2024 年、2024-2029 年、2034 年
  • 乳癌
  • 子宫颈癌
  • 大肠直肠癌
  • 肺癌
  • 全球下一代肿瘤设备和解决方案市场（按技术、实际成果值和预测），2019-2024 年、2024-2029 年、2034 年
  • 次世代定序（NGS）
  • 聚合酵素链锁反应（PCR）
  • DNA微阵列
  • 多路復用
  • 其他技术
  • 全球下一代肿瘤设备和解决方案市场的应用、实际成果值和预测值（2019-2024 年、2024-2029 年和 2034 年）
  • 筛检和早期检测
  • 预测和监测
  • 治疗方法方案
  • 復发监测
  • 其他用途
  • 全球下一代肿瘤设备和解决方案市场按最终用途、实际成果值和预测值，2019-2024 年、2024-2029 年、2034 年
  • 医院和诊所
  • 诊断实验室
  • 学术研究所
  • 其他最终用户
  • 全球下一代肿瘤设备和解决方案市场（按乳癌类型、实际成果值和预测值），2019-2024 年、2024-2029 年、2034 年
  • 浸润性乳管癌
  • 浸润性小叶癌
  • 三阴性乳癌
  • HER2阳性乳癌
  • 全球下一代肿瘤设备和解决方案市场（按子宫颈癌类型、实际成果值和预测值），2019-2024 年、2024-2029 年、2034 年
  • 鳞状细胞癌
  • 腺癌
  • 腺鳞癌
  • 全球下一代肿瘤设备和解决方案市场按结直肠癌类型、实际成果值和预测值，2019-2024 年、2024-2029 年、2034 年
  • 大肠直肠癌
  • 直肠癌
  • 转移性大肠直肠癌
  • 全球下一代肿瘤设备和解决方案市场（按肺癌类型、实际成果值和预测值），2019-2024 年、2024-2029 年、2034 年
  • 非小细胞肺癌（NSCLC）
  • 小细胞肺癌（SCLC）
  • 肺腺癌
  • 鳞状细胞肺癌

第七章 区域和国家分析

  • 全球下一代肿瘤设备和解决方案市场（按地区、实际成果值和预测）2019-2024 年、2024-2029 年、2034 年
  • 全球下一代肿瘤设备和解决方案市场（按国家/地区划分）、实际成果值和预测（2019-2024 年、2024-2029 年、2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 下一代肿瘤设备和解决方案市场：竞争格局
  • 下一代肿瘤设备和解决方案市场：公司简介
    • 强生服务公司（概况、产品与服务、策略、财务分析）
    • 西门子股份公司（概况、产品与服务、策略、财务分析）
    • 默克公司（概况、产品与服务、策略、财务分析）
    • 赛默飞世尔科技公司（概况、产品与服务、策略、财务分析）
    • 诺华公司（概况、产品与服务、策略、财务分析）

第31章 其他大型创新企业

  • Koninklijke Philips NV
  • GE HealthCare Technologies Inc.
  • Agilent Technologies Inc.
  • Illumina Inc.
  • Sysmex Corporation
  • QIAGEN NV
  • Exact Sciences Corporation
  • Elekta AB
  • Myriad Genetics Inc.
  • Takara Bio USA Inc.
  • NeoGenomics Inc.
  • Guardant Health Inc.
  • Accuray Incorporated
  • SOPHiA GENETICS SA
  • Paige.AI Inc.

第 32 章全球市场：竞争基准化分析板

第33章 重大企业合併（M&A）

第34章近期市场趋势

第35章：具有高市场潜力的国家、产业与策略

  • 下一代肿瘤设备和解决方案市场：提供新机会的国家（2029 年）
  • 下一代肿瘤设备和解决方案市场：提供新机会的产业（2029 年）
  • 下一代肿瘤设备和解决方案市场：成长策略（2029年）
    • 基于市场趋势的策略
    • 竞争策略

第36章 附录

简介目录
Product Code: r35527

Next-generation oncology devices and solutions encompass advanced technologies and tools developed to detect, diagnose, monitor, and treat various forms of cancer with enhanced precision and speed. Their goal is to facilitate personalized cancer care by utilizing innovations such as next-generation sequencing, digital pathology, and targeted therapies to improve patient outcomes.

The primary cancer types addressed by next-generation oncology devices and solutions include breast cancer, cervical cancer, colorectal cancer, and lung cancer. Breast cancer is a condition where cells in the breast grow uncontrollably, often forming a tumor that can be felt as a lump or identified through imaging. These solutions employ technologies such as next-generation sequencing (NGS), polymerase chain reaction (PCR), DNA microarrays, multiplexing, and other advanced techniques, which are applied in areas such as screening and early detection, prognostics and monitoring, therapy selection, and recurrence monitoring. The key end users include hospitals and clinics, diagnostic laboratories, academic and research institutions, and more.

The next-generation oncology devices and solutions market research report is one of a series of new reports from The Business Research Company that provides next-generation oncology devices and solutions market statistics, including the next-generation oncology devices and solutions industry global market size, regional shares, competitors with the next-generation oncology devices and solutions market share, detailed next-generation oncology devices and solutions market segments, market trends, and opportunities, and any further data you may need to thrive in the next-generation oncology devices and solutions industry. This next-generation oncology devices and solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The next-generation oncology devices and solutions market size has grown rapidly in recent years. It will grow from $13.90 billion in 2024 to $16.52 billion in 2025 at a compound annual growth rate (CAGR) of 18.9%. The growth observed in the historical period can be attributed to the increasing global cancer incidence, expansion of oncology research and clinical trials, advancements in precision medicine, growth of hospital and diagnostic infrastructure, and greater awareness of early cancer screening.

The next-generation oncology devices and solutions market size is expected to see rapid growth in the next few years. It will grow to $32.73 billion in 2029 at a compound annual growth rate (CAGR) of 18.6%. The growth anticipated in the forecast period is driven by the aging global population, increased investment in oncology startups, rising healthcare expenditures, greater demand for non-invasive or minimally invasive diagnostics, and the development of healthcare infrastructures. Key trends in the forecast period include AI-powered diagnostic imaging, advancements in liquid biopsy, personalized medicine platforms, wearable health monitoring devices, robotics, and minimally invasive surgical tools.

The growing prevalence of cancer is expected to drive the expansion of the next-generation oncology devices and solutions market. Cancer is a disease characterized by uncontrolled growth of abnormal cells, which can spread to other areas of the body, disrupting normal functions. The increasing prevalence of cancer is mainly due to aging populations, as the risk of developing cancer rises with age. Next-generation oncology devices and solutions help address this rise by enabling earlier detection, more accurate diagnosis, and personalized treatment. For example, in January 2024, the American Cancer Society, a US-based nonprofit organization, estimated that cancer would cause over 611,000 deaths in the United States, which equals more than 1,600 cancer-related deaths per day. As such, the growing prevalence of cancer is a key driver for the growth of the next-generation oncology devices and solutions market.

Leading companies in the next-generation oncology devices and solutions market are focusing on technological innovations, such as next-generation sequencing (NGS) target enrichment solutions, to improve the detection of rare genetic variants, enhance sequencing accuracy, and expedite cancer diagnosis and treatment decisions. NGS target enrichment solutions involve techniques that selectively capture and concentrate specific DNA or RNA regions for sequencing, allowing more precise and efficient analysis of genetic variants associated with cancer and other diseases. For instance, in April 2025, Integrated DNA Technologies (IDT), a US-based biotechnology company, launched the xGen Hybridization and Wash v3 Kit, an advanced hybridization capture solution designed to accelerate cancer research by streamlining NGS workflows. This kit reduces hybridization time to just one hour, enabling researchers to complete sample preparation and sequencing in a single workday. By eliminating the need for heated buffers and cutting hands-on time by 20%, the solution is highly automation-friendly and ideal for high-throughput applications.

In July 2024, Hologic, a US-based medical technology company, acquired Endomag for an undisclosed amount. This acquisition aims to enhance Hologic's breast cancer surgery portfolio by incorporating Endomag's innovative surgical guidance products, which improve the precision and effectiveness of cancer care. Endomag, a UK-based medical device manufacturer, specializes in surgical guidance products for breast cancer treatment.

Major players in the next-generation oncology devices and solutions market are Johnson & Johnson Services Inc., Siemens AG, Merck & Co. Inc., Thermo Fisher Scientific Inc., Novartis AG, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Elekta AB, Myriad Genetics Inc., Takara Bio USA Inc., NeoGenomics Inc., Guardant Health Inc., Accuray Incorporated, SOPHiA GENETICS SA, Paige.AI Inc., Deep Bio Inc., and Lucida Medical Ltd.

North America was the largest region in the next-generation oncology devices and solutions market in 2024. The regions covered in next-generation oncology devices and solutions report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the next-generation oncology devices and solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The next-generation oncology devices and solutions market consists of revenues earned by entities by providing services such as cancer genomic profiling and sequencing, personalized treatment planning, remote patient monitoring and tele-oncology, and early cancer detection and screening. The market value includes the value of related goods sold by the service provider or included within the service offering. The next-generation oncology devices and solutions market also includes sales of liquid biopsy kits, companion diagnostic tests, digital pathology systems, cancer biomarker detection assays, and targeted therapy monitoring devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Next-Generation Oncology Devices And Solutions Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on next-generation oncology devices and solutions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for next-generation oncology devices and solutions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The next-generation oncology devices and solutions market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Cancer Type: Breast Cancer; Cervical Cancer; Colorectal Cancer; Lung Cancer
  • 2) By Technology: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); DNA Microarrays; Multiplexing; Other Technologies
  • 3) By Application: Screening And Early Detection; Prognostics And Monitoring; Therapy Selection; Recurrence Monitoring; Other Applications
  • 4) By End Use: Hospitals And Clinics; Diagnostic Laboratories; Academic And Research Institutions; Other End Uses
  • Subsegments:
  • 1) By Breast Cancer: Invasive Ductal Carcinoma; Invasive Lobular Carcinoma; Triple-Negative Breast Cancer; HER2-Positive Breast Cancer
  • 2) By Cervical Cancer: Squamous Cell Carcinoma; Adenocarcinoma; Adenosquamous Carcinoma
  • 3) By Colorectal Cancer: Colon Cancer; Rectal Cancer; Metastatic Colorectal Cancer
  • 4) By Lung Cancer: Non-Small Cell Lung Cancer (NSCLC); Small Cell Lung Cancer (SCLC); Lung Adenocarcinoma; Squamous Cell Lung Carcinoma
  • Companies Mentioned: Johnson & Johnson Services Inc.; Siemens AG; Merck & Co. Inc.; Thermo Fisher Scientific Inc.; Novartis AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Next-Generation Oncology Devices And Solutions Market Characteristics

3. Next-Generation Oncology Devices And Solutions Market Trends And Strategies

4. Next-Generation Oncology Devices And Solutions Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Next-Generation Oncology Devices And Solutions Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Next-Generation Oncology Devices And Solutions PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Next-Generation Oncology Devices And Solutions Market Growth Rate Analysis
  • 5.4. Global Next-Generation Oncology Devices And Solutions Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Next-Generation Oncology Devices And Solutions Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Next-Generation Oncology Devices And Solutions Total Addressable Market (TAM)

6. Next-Generation Oncology Devices And Solutions Market Segmentation

  • 6.1. Global Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Breast Cancer
  • Cervical Cancer
  • Colorectal Cancer
  • Lung Cancer
  • 6.2. Global Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • DNA Microarrays
  • Multiplexing
  • Other Technologies
  • 6.3. Global Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Screening And Early Detection
  • Prognostics And Monitoring
  • Therapy Selection
  • Recurrence Monitoring
  • Other Applications
  • 6.4. Global Next-Generation Oncology Devices And Solutions Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Diagnostic laboratories
  • Academic And Research Institutions
  • Other End Users
  • 6.5. Global Next-Generation Oncology Devices And Solutions Market, Sub-Segmentation Of Breast Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Invasive Ductal Carcinoma
  • Invasive Lobular Carcinoma
  • Triple-Negative Breast Cancer
  • HER2-Positive Breast Cancer
  • 6.6. Global Next-Generation Oncology Devices And Solutions Market, Sub-Segmentation Of Cervical Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Squamous Cell Carcinoma
  • Adenocarcinoma
  • Adenosquamous Carcinoma
  • 6.7. Global Next-Generation Oncology Devices And Solutions Market, Sub-Segmentation Of Colorectal Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Colon Cancer
  • Rectal Cancer
  • Metastatic Colorectal Cancer
  • 6.8. Global Next-Generation Oncology Devices And Solutions Market, Sub-Segmentation Of Lung Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Non-Small Cell Lung Cancer (NSCLC)
  • Small Cell Lung Cancer (SCLC)
  • Lung Adenocarcinoma
  • Squamous Cell Lung Carcinoma

7. Next-Generation Oncology Devices And Solutions Market Regional And Country Analysis

  • 7.1. Global Next-Generation Oncology Devices And Solutions Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Next-Generation Oncology Devices And Solutions Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Next-Generation Oncology Devices And Solutions Market

  • 8.1. Asia-Pacific Next-Generation Oncology Devices And Solutions Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Next-Generation Oncology Devices And Solutions Market

  • 9.1. China Next-Generation Oncology Devices And Solutions Market Overview
  • 9.2. China Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Next-Generation Oncology Devices And Solutions Market

  • 10.1. India Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Next-Generation Oncology Devices And Solutions Market

  • 11.1. Japan Next-Generation Oncology Devices And Solutions Market Overview
  • 11.2. Japan Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Next-Generation Oncology Devices And Solutions Market

  • 12.1. Australia Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Next-Generation Oncology Devices And Solutions Market

  • 13.1. Indonesia Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Next-Generation Oncology Devices And Solutions Market

  • 14.1. South Korea Next-Generation Oncology Devices And Solutions Market Overview
  • 14.2. South Korea Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Next-Generation Oncology Devices And Solutions Market

  • 15.1. Western Europe Next-Generation Oncology Devices And Solutions Market Overview
  • 15.2. Western Europe Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Next-Generation Oncology Devices And Solutions Market

  • 16.1. UK Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Next-Generation Oncology Devices And Solutions Market

  • 17.1. Germany Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Next-Generation Oncology Devices And Solutions Market

  • 18.1. France Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Next-Generation Oncology Devices And Solutions Market

  • 19.1. Italy Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Next-Generation Oncology Devices And Solutions Market

  • 20.1. Spain Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Next-Generation Oncology Devices And Solutions Market

  • 21.1. Eastern Europe Next-Generation Oncology Devices And Solutions Market Overview
  • 21.2. Eastern Europe Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Next-Generation Oncology Devices And Solutions Market

  • 22.1. Russia Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Next-Generation Oncology Devices And Solutions Market

  • 23.1. North America Next-Generation Oncology Devices And Solutions Market Overview
  • 23.2. North America Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Next-Generation Oncology Devices And Solutions Market

  • 24.1. USA Next-Generation Oncology Devices And Solutions Market Overview
  • 24.2. USA Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Next-Generation Oncology Devices And Solutions Market

  • 25.1. Canada Next-Generation Oncology Devices And Solutions Market Overview
  • 25.2. Canada Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Next-Generation Oncology Devices And Solutions Market

  • 26.1. South America Next-Generation Oncology Devices And Solutions Market Overview
  • 26.2. South America Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Next-Generation Oncology Devices And Solutions Market

  • 27.1. Brazil Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Next-Generation Oncology Devices And Solutions Market

  • 28.1. Middle East Next-Generation Oncology Devices And Solutions Market Overview
  • 28.2. Middle East Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Next-Generation Oncology Devices And Solutions Market

  • 29.1. Africa Next-Generation Oncology Devices And Solutions Market Overview
  • 29.2. Africa Next-Generation Oncology Devices And Solutions Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Next-Generation Oncology Devices And Solutions Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Next-Generation Oncology Devices And Solutions Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Next-Generation Oncology Devices And Solutions Market Competitive Landscape And Company Profiles

  • 30.1. Next-Generation Oncology Devices And Solutions Market Competitive Landscape
  • 30.2. Next-Generation Oncology Devices And Solutions Market Company Profiles
    • 30.2.1. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Siemens AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Next-Generation Oncology Devices And Solutions Market Other Major And Innovative Companies

  • 31.1. Koninklijke Philips N.V.
  • 31.2. GE HealthCare Technologies Inc.
  • 31.3. Agilent Technologies Inc.
  • 31.4. Illumina Inc.
  • 31.5. Sysmex Corporation
  • 31.6. QIAGEN N.V.
  • 31.7. Exact Sciences Corporation
  • 31.8. Elekta AB
  • 31.9. Myriad Genetics Inc.
  • 31.10. Takara Bio USA Inc.
  • 31.11. NeoGenomics Inc.
  • 31.12. Guardant Health Inc.
  • 31.13. Accuray Incorporated
  • 31.14. SOPHiA GENETICS SA
  • 31.15. Paige.AI Inc.

32. Global Next-Generation Oncology Devices And Solutions Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Next-Generation Oncology Devices And Solutions Market

34. Recent Developments In The Next-Generation Oncology Devices And Solutions Market

35. Next-Generation Oncology Devices And Solutions Market High Potential Countries, Segments and Strategies

  • 35.1 Next-Generation Oncology Devices And Solutions Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Next-Generation Oncology Devices And Solutions Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Next-Generation Oncology Devices And Solutions Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer